InhibrxInc Historical Cash Flow
| INBX Stock | USD 34.13 0.03 0.09% |
Analysis of InhibrxInc cash flow over time is an excellent tool to project InhibrxInc future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Change To Operating Activities of 6.9 M or End Period Cash Flow of 291.8 M as it is a great indicator of InhibrxInc ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining InhibrxInc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether InhibrxInc is a good buy for the upcoming year.
InhibrxInc |
About InhibrxInc Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in InhibrxInc balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which InhibrxInc's non-liquid assets can be easily converted into cash.
InhibrxInc Cash Flow Chart
InhibrxInc Cash Flow Statement became part of mandatory reporting in 1987. It is now one of three main statements in accounting used to measure how well a company manages its liquidity and overall cash position. The rate of cash utilization and preservation is now part of the leading indicators of a healthy entity, and the InhibrxInc Cash Flow Statement shows how well the company generates cash to payout debt obligations or to cover ongoing operating expenses.
At this time, InhibrxInc's Change Receivables is fairly stable compared to the past year. Add Fundamental
Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Most accounts from InhibrxInc's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into InhibrxInc current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in InhibrxInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. For more information on how to buy InhibrxInc Stock please use our How to Invest in InhibrxInc guide.At this time, InhibrxInc's Change Receivables is fairly stable compared to the past year.
| 2021 | 2022 | 2023 | 2024 (projected) | Other Non Cash Items | 2.7M | 5.1M | 8.2M | 6.1M | Depreciation | 1.2M | 1.2M | 1.2M | 1.1M |
InhibrxInc cash flow statement Correlations
Click cells to compare fundamentals
InhibrxInc Account Relationship Matchups
High Positive Relationship
High Negative Relationship
InhibrxInc cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Net Borrowings | 33.8M | 41.4M | 40.0M | 128.9M | 148.2M | 155.6M | |
| Total Cashflows From Investing Activities | (1.8M) | (1.4M) | (809K) | (686K) | (617.4K) | (648.3K) | |
| Other Cashflows From Financing Activities | 37.5M | 35.1M | 83.6M | 260.0M | (355K) | (337.3K) | |
| Capital Expenditures | 1.8M | 1.4M | 864K | 686K | 4.6M | 4.8M | |
| Total Cash From Operating Activities | (32.1M) | (48.0M) | (80.3M) | (115.3M) | (193.3M) | (183.6M) | |
| Change To Operating Activities | (2.5M) | 7.8M | (11.0M) | 5.7M | 6.6M | 6.9M | |
| End Period Cash Flow | 11.5M | 128.7M | 131.3M | 273.9M | 277.9M | 291.8M | |
| Change To Netincome | 6.4M | 4.3M | 16.5M | 20.5M | 23.5M | 24.7M | |
| Change To Liabilities | 5.5M | 4.8M | (6.3M) | 6.9M | 7.9M | 8.3M | |
| Change To Inventory | (672K) | (2.5M) | 7.8M | (11.0M) | (9.9M) | (9.4M) | |
| Investments | (1.8M) | (1.4M) | (809K) | (686K) | (4.6M) | (4.4M) | |
| Change In Cash | 9.4M | 117.1M | 2.6M | 142.6M | 4.1M | 3.9M | |
| Stock Based Compensation | 4.0M | 5.0M | 15.0M | 20.5M | 24.8M | 26.1M | |
| Free Cash Flow | (33.9M) | (49.3M) | (81.2M) | (116.0M) | (197.9M) | (188.0M) | |
| Change In Working Capital | 3.5M | 12.7M | (17.5M) | 3.2M | 15.3M | 16.1M | |
| Begin Period Cash Flow | 2.1M | 11.5M | 128.7M | 131.3M | 273.9M | 287.6M | |
| Depreciation | 1.2M | 1.0M | 1.2M | 1.2M | 1.2M | 1.1M | |
| Other Non Cash Items | 9.6M | 11.6M | 2.7M | 5.1M | 8.2M | 6.1M | |
| Change To Account Receivables | 491K | 117K | (167K) | 130K | (521K) | (495.0K) | |
| Net Income | (51.4M) | (76.1M) | (81.8M) | (145.2M) | (241.4M) | (229.3M) | |
| Total Cash From Financing Activities | 43.3M | 166.5M | 83.8M | 258.6M | 202.0M | 122.7M | |
| Issuance Of Capital Stock | 12M | 136.9M | 40.2M | 127.4M | 200M | 210M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in InhibrxInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. For more information on how to buy InhibrxInc Stock please use our How to Invest in InhibrxInc guide.Note that the InhibrxInc information on this page should be used as a complementary analysis to other InhibrxInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Complementary Tools for InhibrxInc Stock analysis
When running InhibrxInc's price analysis, check to measure InhibrxInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InhibrxInc is operating at the current time. Most of InhibrxInc's value examination focuses on studying past and present price action to predict the probability of InhibrxInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InhibrxInc's price. Additionally, you may evaluate how the addition of InhibrxInc to your portfolios can decrease your overall portfolio volatility.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |
Is InhibrxInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of InhibrxInc. If investors know InhibrxInc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about InhibrxInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.12) | Revenue Per Share 0.038 | Quarterly Revenue Growth 4.964 | Return On Assets (0.46) | Return On Equity (4.75) |
The market value of InhibrxInc is measured differently than its book value, which is the value of InhibrxInc that is recorded on the company's balance sheet. Investors also form their own opinion of InhibrxInc's value that differs from its market value or its book value, called intrinsic value, which is InhibrxInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because InhibrxInc's market value can be influenced by many factors that don't directly affect InhibrxInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between InhibrxInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if InhibrxInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, InhibrxInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.